Skip to main navigation Skip to search Skip to main content

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience

  • Luca Laurenti*
  • , Francesco Autore
  • , Idanna Innocenti
  • , Giovanni D’Arena
  • , Marta Coscia
  • , Patrizia Mondello
  • , Patrizia Chiusolo
  • , Silvia Bellesi
  • , Dimitar G. Efremov
  • , Simona Sica
  • , Francesca Romana Mauro
  • *Corresponding author

Research output: Contribution to journalArticle

Abstract

utoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients
Original languageEnglish
Pages (from-to)2429-2431
Number of pages3
JournalLEUKEMIA & LYMPHOMA
Volume57
DOIs
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cancer Research
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience'. Together they form a unique fingerprint.

Cite this